日清食品(01475.HK)成為東京2020殘疾人奧運會中國香港代表團食品夥伴
日清食品(01475.HK)宣布,成為東京2020殘疾人奧運會中國香港代表團食品夥伴,同時亦會繼續贊助港隊參與10月將於陝西省舉行的中華人民共和國第十一屆殘疾人運動會,以及12月的巴林2021亞洲青少年殘疾人運動會。
日清食品董事長兼首席執行官安藤清隆表示,香港運動員自1972年至今已參與12屆殘疾人奧運會,共取得126面獎牌,成績驕人﹐祝願運動員能突破極限,代表團在東京殘奧運再創佳績,並感謝東奧組委會在備受疫情影響的困難時期盡力舉行賽事。
他表示,日清將繼續支持本地比賽和訓練,培養嶄露頭角及具潛質的運動員,亦會繼續贊助本地精英運動員參加海外的國際賽事。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.